Italy e-Cigarette Market Report 2024: Growing Trend Towards Simpler Devices
June 14, 2024 07:09 ET
|
Research and Markets
Dublin, June 14, 2024 (GLOBE NEWSWIRE) -- The "Italy e-Cigarette Market" report has been added to ResearchAndMarkets.com's offering. This report analyses the current state of the Italian vaping...
Ölgerðin Egill Skallagrímsson hf.: Flöggun - Gildi-lífeyrissjóður
June 14, 2024 07:07 ET
|
Ölgerðin Egill Skallagrimsson
Sjá meðfylgjandi tilkynningu um flöggun.
Viðhengi
Flöggun í Ölgerðinni - Gildi upp fyrir 5% (13.6.2024)
...
North America Weight Loss Supplement Market Size, Share & Trends Analysis Report 2024-2030
June 14, 2024 07:07 ET
|
Research and Markets
Dublin, June 14, 2024 (GLOBE NEWSWIRE) -- The "North America Weight Loss Supplement Market Size, Share & Trends Analysis Report by Type (Liquid, Pills), Ingredient (Vitamins & Minerals,...
Invivyd Announces Antiviral Activity of VYD222 (pemivibart) Against SARS-CoV-2 KP.1.1 FLiRT & KP.3 Variants
June 14, 2024 07:01 ET
|
Invivyd
Pseudovirus in vitro neutralization data show continued neutralizing activity of VYD222 (pemivibart) against the KP.1.1 FLiRT and KP.3 SARS-CoV-2 variants, virus selections representative of current...
Medicare Issues Final Coverage Determination for kidneyintelX.dkd
June 14, 2024 07:00 ET
|
Renalytix plc
LONDON and NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that on June 13, 2024 Medicare issued a final Local Coverage Determination ("LCD")...
Ragnarok Online Official Launching in China on June 28, 2024
June 14, 2024 07:00 ET
|
GRAVITY Co., Ltd.
Seoul, South Korea, June 14, 2024 (GLOBE NEWSWIRE) -- GRAVITY Co., Ltd. (NasdaqGM: GRVY) (“Gravity” or “Company”), a developer and publisher of online and mobile games, announces that Ragnarok...
Kymera Therapeutics Presents New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT-333 at EHA Annual Meeting
June 14, 2024 07:00 ET
|
Kymera Therapeutics, Inc.
KT-333 demonstrated initial clinical proof of concept across multiple hematological malignancies, including complete responses in two patients with Hodgkin’s lymphoma Robust STAT3 knockdown and...
Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at European Hematology Association Congress
June 14, 2024 07:00 ET
|
Bio-Path Holdings, Inc.
HOUSTON, June 14, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to...
Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress
June 14, 2024 07:00 ET
|
Autolus Therapeutics plc
Autolus Therapeutics to Present Three Clinical Data Updates on obe-cel at EHA
The names of four new victims of impaired driving have been engraved on the Memorial Artwork in Québec City
June 14, 2024 07:00 ET
|
MADD Canada
QUEBEC CITY, June 14, 2024 (GLOBE NEWSWIRE) -- The families of those who have been killed in impaired driving crashes will gather today to honour the memory of their loved ones and to unveil the...
- June 14, 2024 07:00 ET Volvo Car Canada Collaborates with iconic global fashion brand to unveil curated looks inspired by the new EX30
- June 14, 2024 07:00 ET Tilray Beverages Announces Campaign to Raise Awareness for Men’s Health